Solasia Pharma - Crunchbase Company Profile & Funding

Q: Where is Solasia Pharma's headquarters?

Solasia Pharma is located in Shanghai, Shanghai, China.

Q: Who invested in Solasia Pharma?

Solasia Pharma has 13 investors including Mitsubishi UFJ Capital And Mitsubishi UFJ Trust & Banking.

Q: When was the last funding round for Solasia Pharma?

Solasia Pharma closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Solasia Pharma raised to date?

Solasia Pharma has raised obfuscated.

Overview

Solasia Pharma

Total Funding

obfuscation

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Solasia Pharma

CB Rank

4039608

Solasia Pharma is a pharmaceutical company that develops and markets drugs as well as medical devices.

Founded

obfuscation

Public

Venture - Series Unknown

Shanghai, Shanghai, China

11-50

solasia.co.jp

Manufacturing

Medical Device

Pharmaceutical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Corporate Round

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Bard Geesaman: Founder
Past Role: F2 Ventures, Partner

Details

Legal Name

Solasia Pharma K.K.

Operating Status

Active

Stock Symbol

TYO:4597

Company Type

For Profit

Founders

Bard Geesaman

About the Company

Solasia Pharma provides pharmaceuticals and medical equipment. They also provide cancer patients with pharmaceuticals. They have developed several products so far. They import and export medicines and medical equipment.

Phone Number

+81 3-6721-8332

Predictions & Insights

Products & Services

DARVIAS® (SP-02)

An intravenous drug for treating peripheral T-cell lymphoma, approved and marketed in Japan with ongoing development for additional indications and international approvals.

episil® oral liquid (SP-03)

A medical device liquid that forms a protective film to relieve pain from oral mucositis, used by patients undergoing chemotherapy or radiotherapy.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Solasia Pharma	3	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Solasia Pharma	3	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Solasia Pharma	3	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Solasia Pharma	3	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Solasia Pharma	3	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Solasia Pharma	3	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Solasia Pharma	3	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Solasia Pharma	3	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Solasia Pharma	3	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Solasia Pharma	3	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Mitsubishi UFJ Capital	—	Venture Round - Solasia Pharma	—
Mitsubishi UFJ Capital	—	Venture Round - Solasia Pharma	—
Mitsubishi UFJ Capital	—	Venture Round - Solasia Pharma	—
Mitsubishi UFJ Capital	—	Venture Round - Solasia Pharma	—
Mitsubishi UFJ Capital	—	Venture Round - Solasia Pharma	—